165 related articles for article (PubMed ID: 21695596)
1. The nucleosome binding protein NSBP1 is highly expressed in human bladder cancer and promotes the proliferation and invasion of bladder cancer cells.
Wahafu W; He ZS; Zhang XY; Zhang CJ; Yao K; Hao H; Song G; He Q; Li XS; Zhou LQ
Tumour Biol; 2011 Oct; 32(5):931-9. PubMed ID: 21695596
[TBL] [Abstract][Full Text] [Related]
2. MiR-186 suppresses the growth and metastasis of bladder cancer by targeting NSBP1.
Yao K; He L; Gan Y; Zeng Q; Dai Y; Tan J
Diagn Pathol; 2015 Aug; 10():146. PubMed ID: 26290438
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of the nucleosome binding protein 1 inhibits the growth and invasion of clear cell renal cell carcinoma cells in vitro and in vivo.
Ji SQ; Yao L; Zhang XY; Li XS; Zhou LQ
J Exp Clin Cancer Res; 2012 Mar; 31(1):22. PubMed ID: 22420896
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of the nucleosome-binding protein 1 (NSBP1) gene can inhibit the in vitro and in vivo proliferation of prostate cancer cells.
Jiang N; Zhou LQ; Zhang XY
Asian J Androl; 2010 Sep; 12(5):709-17. PubMed ID: 20531280
[TBL] [Abstract][Full Text] [Related]
5. Suppression of nucleosome-binding protein 1 by miR-326 impedes cell proliferation and invasion in non-small cell lung cancer cells.
Li D; Du X; Liu A; Li P
Oncol Rep; 2016 Feb; 35(2):1117-24. PubMed ID: 26548724
[TBL] [Abstract][Full Text] [Related]
6. [Expression of nucleosomal binding protein 1 in normal prostate benign prostate hyperplasia, and prostate cancer and significance thereof].
Song G; Zhou LQ; Weng M; He Q; He ZS; Hao JR; Pan BN; Na YQ
Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(28):1962-5. PubMed ID: 17064590
[TBL] [Abstract][Full Text] [Related]
7. The high-mobility group nucleosome-binding domain 5 is highly expressed in breast cancer and promotes the proliferation and invasion of breast cancer cells.
Weng M; Song F; Chen J; Wu J; Qin J; Jin T; Xu J
Tumour Biol; 2015 Feb; 36(2):959-66. PubMed ID: 25315189
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of HMGN5 suppresses the viability and invasion of human urothelial bladder cancer 5637 cells in vitro and in vivo.
Gan Y; Tan J; Yang J; Zhou Y; Dai Y; He L; Yao K; Tang Y
Med Oncol; 2015 Apr; 32(4):136. PubMed ID: 25796505
[TBL] [Abstract][Full Text] [Related]
9. High expression of polo-like kinase 1 is associated with the metastasis and recurrence in urothelial carcinoma of bladder.
Zhang Z; Zhang G; Kong C
Urol Oncol; 2013 Oct; 31(7):1222-30. PubMed ID: 22192978
[TBL] [Abstract][Full Text] [Related]
10. HMGN5 expression in bladder cancer tissue and its role on prognosis.
Wu J; Wang J
Eur Rev Med Pharmacol Sci; 2018 Feb; 22(4):970-975. PubMed ID: 29509244
[TBL] [Abstract][Full Text] [Related]
11. The expression and clinical significance of high mobility group nucleosome binding domain 5 in human osteosarcoma.
Zhou X; Yuan B; Yuan W; Wang C; Gao R; Wang J
Tumour Biol; 2014 Jul; 35(7):6539-47. PubMed ID: 24687550
[TBL] [Abstract][Full Text] [Related]
12. Heat-shock protein 70-2 (HSP70-2) expression in bladder urothelial carcinoma is associated with tumour progression and promotes migration and invasion.
Garg M; Kanojia D; Seth A; Kumar R; Gupta A; Surolia A; Suri A
Eur J Cancer; 2010 Jan; 46(1):207-15. PubMed ID: 19914824
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of immunoglobulin G prompts cell proliferation and inhibits cell apoptosis in human urothelial carcinoma.
Liang PY; Li HY; Zhou ZY; Jin YX; Wang SX; Peng XH; Ou SJ
Tumour Biol; 2013 Jun; 34(3):1783-91. PubMed ID: 23483488
[TBL] [Abstract][Full Text] [Related]
14. High expression of SMYD3 indicates poor survival outcome and promotes tumour progression through an IGF-1R/AKT/E2F-1 positive feedback loop in bladder cancer.
Wang G; Huang Y; Yang F; Tian X; Wang K; Liu L; Fan Y; Li X; Li L; Shi B; Hao Y; Xia C; Nie Q; Xin Y; Shi Z; Ma L; Xu D; Liu C
Aging (Albany NY); 2020 Feb; 12(3):2030-2048. PubMed ID: 32007952
[TBL] [Abstract][Full Text] [Related]
15. p63 gene expression study and early bladder carcinogenesis.
Compérat E; Bièche I; Dargère D; Ferlicot S; Laurendeau I; Benoît G; Vieillefond A; Verret C; Vidaud M; Capron F; Bedossa P; Paradis V
Urology; 2007 Sep; 70(3):459-62. PubMed ID: 17905096
[TBL] [Abstract][Full Text] [Related]
16. HMGN5 promotes IL-6-induced epithelial-mesenchymal transition of bladder cancer by interacting with Hsp27.
Yao K; He L; Gan Y; Liu J; Tang J; Long Z; Tan J
Aging (Albany NY); 2020 Apr; 12(8):7282-7298. PubMed ID: 32315283
[TBL] [Abstract][Full Text] [Related]
17. The interaction of NSBP1/HMGN5 with nucleosomes in euchromatin counteracts linker histone-mediated chromatin compaction and modulates transcription.
Rochman M; Postnikov Y; Correll S; Malicet C; Wincovitch S; Karpova TS; McNally JG; Wu X; Bubunenko NA; Grigoryev S; Bustin M
Mol Cell; 2009 Sep; 35(5):642-56. PubMed ID: 19748358
[TBL] [Abstract][Full Text] [Related]
18. The nucleosome binding protein 1 promotes the growth of gastric cancer cells.
Liu L; Lang Z; Wang P; Wang H; Cao Y; Meng X; Hu J; Feng Y
J Cancer; 2019; 10(5):1132-1137. PubMed ID: 30854121
[TBL] [Abstract][Full Text] [Related]
19. CD147 overexpression is a prognostic factor and a potential therapeutic target in bladder cancer.
Xue YJ; Lu Q; Sun ZX
Med Oncol; 2011 Dec; 28(4):1363-72. PubMed ID: 20509007
[TBL] [Abstract][Full Text] [Related]
20. Expression of Aggrus/podoplanin in bladder cancer and its role in pulmonary metastasis.
Takagi S; Oh-hara T; Sato S; Gong B; Takami M; Fujita N
Int J Cancer; 2014 Jun; 134(11):2605-14. PubMed ID: 24222607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
